Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

KRIBB-11 controls molecular pathways with potential for therapeutic strategy for glioblastoma

July 16, 2021

Tumor suppressor p53 is inactivated by lncRNA

July 16, 2021

AbbVie, Calico Life Sciences patent PROTACs targeting PTPN1 and/or PTPN2

July 16, 2021

FDA lifts partial clinical hold on phase Ib study of RVU-120 in AML and MDS

July 15, 2021

Antibiotics double as antitumor kinase inhibitors

July 15, 2021

Enrollment begins in phase I study of BI-1810631 in advanced solid tumors

July 15, 2021

New G12C mutant GTPase KRAS inhibitors presented by Novartis

July 15, 2021

Merck & Co. discovers protein arginine N-methyltransferase 5 inhibitors

July 15, 2021

Mutant EGFR inhibitors identified at Roche

July 15, 2021

Oral fadraciclib enters phase I/II study in advanced solid tumors

July 14, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026